Ehingen, Germany

Christian Gege

USPTO Granted Patents = 36 

 

 

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Ehingen/Donau, DE (2008 - 2013)
  • Mauer, DE (2010 - 2022)
  • Ehingen, DE (2007 - 2024)

Company Filing History:


Years Active: 2007-2025

where 'Filed Patents' based on already Granted Patents

36 patents (USPTO):

Title: The Innovative Contributions of Christian Gege

Introduction

Christian Gege, a distinguished inventor based in Ehingen, Germany, has made significant strides in the field of medicinal chemistry, boasting an impressive portfolio of 33 patents. His work primarily focuses on compounds that target nuclear receptors, providing insights into innovative therapeutic approaches.

Latest Patents

Among Christian's latest patents are "LXR modulators with bicyclic core moiety" and "FXR (NR1H4) modulating compounds." The former relates to bicyclic compounds, such as indoles with sulfonyl moieties, which bind to the liver X receptor (LXRα and/or LXKβ) and function as inverse agonists. The latter patent encompasses compounds that bind to the NR1H4 receptor (FXR), acting as agonists. These discoveries hold promise for treating various diseases through tailored medicaments derived from these innovative compounds.

Career Highlights

Throughout his career, Christian Gege has worked with renowned companies, including Gilead Sciences, Inc. and Janssen Pharmaceutica NV. His role in these organizations has significantly contributed to the advancement of pharmaceutical innovations and research.

Collaborations

Christian has had the privilege of collaborating with esteemed colleagues Olaf Kinzel and Christoph Steeneck. These partnerships have undoubtedly enriched his research endeavors and expanded the horizons of his inventive work.

Conclusion

Christian Gege's contributions to pharmaceutical science through his patents and collaborations highlight his role as an influential inventor. With a focus on innovative therapies and a track record of impactful research, he continues to pave the way for advancements in medicinal chemistry, ultimately benefiting the healthcare field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…